Effect of ganciclovir eye-drops for corneal endothelitis caused by cytomegalovirus infectio

Not Applicable

• Conditions: Cytomegalovirus coreal endotheliitis; Cytomegalovirus, Coreal endotheliitis

• Registration Number: JPRN-jRCTs021180030
• Lead Sponsor: Tando Toshio

Brief Summary

The study started with an investigation of the therapeutic effects of antiviral drugs on cytomegalovirus corneal endotheliitis, but this study was based on off-label use of drugs.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-25
• Study Completion: 2019-11-26
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Cytomegalovirus coreal endotheliitis established by the Japan Corneal Endotheliitis Study Group which was authorised by the Japanese Ministry of Health, Labour and Welfare

Exclusion Criteria

Patients which did not agree to join this clinical trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Corneal condition

Secondary Outcome Measures

Name	Time	Method
Intraocular pressure, Corneal endothelial cells